Social Media Ideas for Alks

Latest updates for Alks

Fresh curated links around ALKS are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /3 weeks ago

Alkermes: 'Buy' On Avadel Acquisition And Positive NT2 Data With Alixorexton

Read source

biopharmadive.com /2 weeks ago

Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda

Blair Jackson says the next 12 months may be the most important in Alkermes’ history, as the brain drugmaker races to join an “orexin” market that analysts see as a multibillion-do...

Read source

seekingalpha.com /1 month ago

Astellas Pharma Inc. (ALPMY) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow

Read source

thehindubusinessline.com /1 month ago

Alkem rolls out single-shot pre-filled syringes of semaglutide

Alkem Laboratories said the one shot pre-filled syringe format expands treatment options for patients and lowers entry barriers by making it affordable

Read source

seekingalpha.com /1 day ago

Amyloidosis Continues To Fight Back

Read source

fool.com /1 month ago

Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter

Alumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases through proprietary TYK2 inhibitors.

Read source

pharmexec.com /1 month ago

<![CDATA[AlzeCure Enters $1 Billion Collaboration and Out-Licensing Agreement with Eli Lilly ]]>

Read source

finance.yahoo.com /2 weeks ago

JPMorgan Cuts PT on Alkami Technology (ALKT) – Here’s Why

Read source

seekingalpha.com /1 week ago

Levicept appoints Darlene Deptula-Hicks as CFO

Read source

seekingalpha.com /1 month ago

Alnylam Pharmaceuticals, Inc. (ALNY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Read source

pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: Alnylam Pharmaceuticals and Inceptive Nucleics Announce 3 Year Strategic Col...

Read source

fiercebiotech.com /1 month ago

Lilly moves deeper into Alzheimer’s research with AlzeCure licensing deal

Eli Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease from AlzeCure Pharma for up to $1 billion biobucks.

Read source

insurancejournal.com /1 week ago

Business Moves: ALKEME Expands in US With Addition of 8 Agencies

Insurance agency ALKEME Insurance said it acquired eight agencies across the U.S. over the second quarter 2026 to enhance its property/casualty offerings in growing markets. Terms...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.